You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信達生物(01801.HK)擬配售5620萬股淨籌27.88億港元 用於建設蘇州達伯舒二期生產設施等
格隆匯 07-24 18:42

格隆匯獲悉,信達生物(01801.HK)7月23日公佈,公司透過摩根士丹利為其一級配售5620萬股新股,佔經擴大後股本約4.02%;配售價每股50港元,較7月22日收市價52.45港元輕微折讓約4.67%。

一級配售所得款項淨額約為27.88億港元,擬用於建設蘇州的達伯舒二期生產設施及與公司增長相匹配的額外產能;為隨着美國研發實驗室擴張而增加的國際臨牀試驗需求提供資金;及用於一般企業用途。

此外,董事會已獲公司執行董事、董事會主席及首席執行官俞德超及Capital International Group(公司在私募階段的一個投資方)告知,擬分別出售或促成出售900萬股及2780萬股,合共3680萬股現有股份(即二級配售股份)(佔於公告日期已發行股份總數約2.74%), 預期二級配售將於2020年7月27日或前後完成。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account